Wilfried van Langenaeker
Keine laufenden Positionen mehr
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Marcel Borgers | M | 84 |
Université Libre de Bruxelles
| 30 Jahre |
Jonathan Faull | M | 69 |
Université Libre de Bruxelles
| 35 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Hans Louis Jos de Winter | M | - |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | 7 Jahre |
Piotr Tyranowski | M | - |
Université Libre de Bruxelles
| 4 Jahre |
Bart de Moor | M | 63 |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
Alain van Gelderen | M | 53 |
Université Libre de Bruxelles
| 6 Jahre |
Gert Adam Irma Thijs | M | - |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | 7 Jahre |
Johan van den Bossche | M | - |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
Didier Georges | M | - |
Université Libre de Bruxelles
| 4 Jahre |
Alain Kupchik | M | - |
Université Libre de Bruxelles
| 5 Jahre |
Marc Hellemans | M | 51 |
Université Libre de Bruxelles
| 4 Jahre |
Qiu Zhi Xue | M | 67 |
Université Libre de Bruxelles
| 3 Jahre |
Daniel Grossmann | M | 53 |
Université Libre de Bruxelles
| 5 Jahre |
Sophie Malarme-Lecloux | F | 53 |
Université Libre de Bruxelles
| 2 Jahre |
Julie Josephine van Hemelryck | F | - |
Université Libre de Bruxelles
| 4 Jahre |
Jean-François Hoffelt | M | 62 |
Université Libre de Bruxelles
| 1 Jahre |
Robert Bury | M | - |
Université Libre de Bruxelles
| 4 Jahre |
Pedro de Boeck | M | 59 |
Université Libre de Bruxelles
| 4 Jahre |
Fabrizio Corradini | M | 57 |
Université Libre de Bruxelles
| 1 Jahre |
Vincent Magnée | M | 53 |
Université Libre de Bruxelles
| 4 Jahre |
Lucrezia A. Reichlin | M | 69 |
Université Libre de Bruxelles
| 14 Jahre |
Muriel de Lathouwer | F | 51 |
Université Libre de Bruxelles
| 4 Jahre |
Vicente Conde Viñuelas | M | - |
Université Libre de Bruxelles
| 3 Jahre |
Filip Kegels | M | 58 |
Université Libre de Bruxelles
| 2 Jahre |
Gaudiana Giusti | F | 61 |
Université Libre de Bruxelles
| 3 Jahre |
Karel Victor Hubert Everaet | M | 59 |
Université Libre de Bruxelles
| 3 Jahre |
Ann J. Barbier | M | 59 |
Université Libre de Bruxelles
| 3 Jahre |
André Boulanger | M | - |
Université Libre de Bruxelles
| 4 Jahre |
Alexandre Kech | M | - |
Université Libre de Bruxelles
| 29 Jahre |
Christian Pierre B van Schoote | M | 59 |
Université Libre de Bruxelles
| 4 Jahre |
Vincent Schobbens | M | 61 |
Université Libre de Bruxelles
| 6 Jahre |
Etienne van de Kerckhove | M | 60 |
Université Libre de Bruxelles
| 4 Jahre |
Marc Wahba | M | - |
Université Libre de Bruxelles
| 4 Jahre |
Ugo Falcinelli | M | - |
Université Libre de Bruxelles
| 1 Jahre |
Kristel Verleyen | F | 53 |
Université Libre de Bruxelles
| 3 Jahre |
Axel Miller | M | 58 |
Université Libre de Bruxelles
| 5 Jahre |
Olivier Roger J. Majérus | M | 62 |
Université Libre de Bruxelles
| 1 Jahre |
Hennie R. Hoogenboom | M | - |
Université Libre de Bruxelles
| 4 Jahre |
Jean-Philippe Waterschoot | M | 61 |
Université Libre de Bruxelles
| 4 Jahre |
Harold Mechelynck | M | - |
Université Libre de Bruxelles
| 1 Jahre |
Chris Baty | M | - |
Université Libre de Bruxelles
| 2 Jahre |
Robert Kiss | M | - |
Université Libre de Bruxelles
| 3 Jahre |
Yvan de Launoit | M | - |
Université Libre de Bruxelles
| 3 Jahre |
Guy Mannaerts | M | - |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
Robert P. Swinnen | M | - |
Université Libre de Bruxelles
| 4 Jahre |
Marc Mommaerts | M | - |
Silicos SA
Silicos SA Pharmaceuticals: MajorHealth Technology Silicos, founded in June 2005, is a chemo-informatics-based biotechnology company empowering proprietary multi-target virtual screening technologies for the discovery of novel and high-quality lead compounds for the treatment of a large variety of diseases, such as cancer, infectious diseases, central nervous system and immunodeficiency diseases. Silicos' proprietary virtual screening technology is based on a unique concept called Spectrophores™, which are descriptors representing all possible three-dimensional molecular properties involved in the binding of a drug to its receptor. Cosmos™ is Silicos' platform for the de novo design of new small molecules optimized towards one or multiple targets. | - |
Christian René Tang-Jespersen | M | 55 |
Université Libre de Bruxelles
| 2 Jahre |
Karim Chouikri | M | 54 |
Université Libre de Bruxelles
| 4 Jahre |
Erik M. van Mulligen | M | - |
Université Libre de Bruxelles
| 2 Jahre |
Marc Josz | M | 66 |
Université Libre de Bruxelles
| 2 Jahre |
Christian Leclercq | M | - |
Université Libre de Bruxelles
| 4 Jahre |
Louis Martens | M | 62 |
Université Libre de Bruxelles
| 4 Jahre |
Benjamin Gigot | M | - |
Université Libre de Bruxelles
| 6 Jahre |
Jack Veuskens | M | - |
Université Libre de Bruxelles
| 3 Jahre |
Jos Sluys | M | 61 |
Université Libre de Bruxelles
| 4 Jahre |
Genco Sanli | M | - |
Université Libre de Bruxelles
| 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Belgien | 56 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Wilfried van Langenaeker
- Persönliches Netzwerk